Upload Image (Max 20MB per Image)
Naurex has announced the issuance of new US patent for selective NMDA receptor partial agonist, GLYX-13, covering methods of treating major depressive disorder through 2030. In a Phase II trial, GLYX-13 demonstrated considerable safety, ...
Tags: Naurex, GLYX-13